Perfluoroalkyl substance exposure is associated with asthma and innate immune cell count in US adolescents stratified by sex
Authors:
- 25 February 2023
- journal article
- research article
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 30 (18) , 52535-52548
Abstract
Exposure to perfluoroalkyl substances (PFAS) may be harmful to humans; however, previous studies have been inconsistent regarding the potential for PFAS-induced immunosuppresion. This study explored the relationship between PFAS exposure and risks of asthma, wheezing, and immunosuppression in 12–19 year-olds using the National Health and Nutrition Examination Survey (NHANES) data. Logistic regression models were used to reveal associations between serum PFAS levels and risks of asthma, wheezing, asthma attack, and emergency department visits. Pearson’s correlation was used to determine the relationship between serum PFAS levels and leukocyte count. Data were also stratified by sex. We found that medium–low levels of serum perfluorooctane sulfonate (PFOS) (6.90–12.40 ng/mL) and serum perfluorooctanoic acid (PFOA) (2.43–3.60 ng/mL) were negatively related, respectively, to current asthma and wheezing in boys, and to wheezing in girls. Meanwhile, boys with medium–high levels (1.50–3.00 ng/mL) of serum perfluorohexanesulfonate (PFHxS) had a high risk of wheezing. Among asthmatic participants, both medium–high levels (3.75–5.07 ng/mL) of serum PFOA and high levels (> 3.92 ng/mL) of PFHxS correlated with asthma attacks in boys; likewise, medium–low levels (0.70–0.99 ng/mL) of serum PFNA correlated with asthma attacks in girls. Also, PFOA and PFNA levels were weakly positively correlated with basophil count, whereas PFOS levels were weakly negatively correlated with eosinophils in asthmatic boys, indicating that basophils may be important in the immune response to PFAS exposure among asthmatics.Keywords
Funding Information
- Jiangsu Commission of Health (CXTDB 2017016)
- Wuxi Health and Family Planning Commission (Q201837, Z202016, QNRC071, HB2020088, FYKY202204)
This publication has 63 references indexed in Scilit:
- Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeedingEnvironmental Research, 2016
- Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12–19 y: National Health and Nutrition Examination SurveyPediatric Research, 2015
- Breastfeeding as an Exposure Pathway for Perfluorinated AlkylatesEnvironmental Science & Technology, 2015
- Prenatal exposure to environmental chemical contaminants and asthma and eczema in school-age childrenAllergy, 2015
- Perfluoroalkyl Chemicals and Asthma among Children 12–19 Years of Age: NHANES (1999–2008)Environmental Health Perspectives, 2014
- Serum Polyfluoroalkyl Concentrations, Asthma Outcomes, and Immunological Markers in a Case–Control Study of Taiwanese ChildrenEnvironmental Health Perspectives, 2013
- Exceptionally High Serum Concentrations of Perfluorohexanesulfonate in a Canadian Family are Linked to Home Carpet Treatment ApplicationsEnvironmental Science & Technology, 2012
- Perfluoroalkyl and polyfluoroalkyl substances (PFASs) in consumer products in Norway – A pilot studyChemosphere, 2012
- Sources, Fate and Transport of PerfluorocarboxylatesEnvironmental Science & Technology, 2005
- Inflammatory cells in asthma: Mechanisms and implications for therapyJournal of Allergy and Clinical Immunology, 2003